Suppr超能文献

p38丝裂原活化蛋白激酶在大鼠心脏缺血预处理中的作用

Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.

作者信息

Bell James R, Eaton Philip, Shattock Michael J

机构信息

Cardiac Physiology, Cardiovascular Division, King's College London, The Rayne Institute, St Thomas' Hospital, London, UK.

出版信息

Clin Exp Pharmacol Physiol. 2008 Feb;35(2):126-34. doi: 10.1111/j.1440-1681.2007.04794.x. Epub 2007 Sep 24.

Abstract
  1. Activation of p38-mitogen-activated protein kinase (MAPK) has been implicated in the signalling cascade leading to protection by ischaemic preconditioning. This, however, is controversial and there is a plethora of conflicting data in the literature. Although many experimental differences may contribute to this, two in particular may be confounding: (i) the failure to account for p38-MAPK activation during aerobic perfusion; and (ii) the use of the anti-oxidant dimethylsulphoxide (DMSO) as the vehicle for the commonly used p38-MAPK inhibitor SB203580. We have investigated the effects of aerobic perfusion, ischaemia and preconditioning on p38-MAPK activation. In addition, we have used water-soluble SB203580 hydrochloride (SB203580.HCl) and DMSO to probe the role of p38-MAPK in preconditioning and ischaemic injury. 2. Activation of p38-MAPK in rat isolated hearts was assessed using a dual phosphospecific antibody during cannulation, aerobic perfusion and index, autolytic and preconditioned ischaemia. The effect of SB203580.HCl (10 mmol/L) in ischaemic preconditioning and ischaemia/reperfusion was tested using recovery of function and tetrazolium (TTC) staining as end-points. 3. Aerobic perfusion induced rapid activation (34% of maximal ischaemia-induced increase; P < 0.05) of p38-MAPK after 2 min that returned to baseline after 30 min. Index, autolytic and preconditioned ischaemia activated p38-MAPK, with index ischaemia peaking after 15 min (520% of basal; P < 0.05) before declining. SB203580.HCl blocked p38-MAPK activity, but did not block ischaemic preconditioning when bracketing the trigger phase and was not protective when given during ischaemia. 4. In the rat isolated heart, activation of p38-MAPK is neither a unique feature of preconditioning nor a prerequisite. Previous studies using SB203580 may have been complicated by failure to account for the activation of p38-MAPK by the protocol itself and the anti-oxidant properties of the most commonly used vehicle DMSO.
摘要
  1. p38丝裂原活化蛋白激酶(MAPK)的激活与缺血预处理导致保护作用的信号级联反应有关。然而,这一点存在争议,文献中有大量相互矛盾的数据。尽管许多实验差异可能导致了这种情况,但有两点尤其可能造成混淆:(i)未能考虑有氧灌注期间p38-MAPK的激活;(ii)使用抗氧化剂二甲基亚砜(DMSO)作为常用p38-MAPK抑制剂SB203580的溶剂。我们研究了有氧灌注、缺血和预处理对p38-MAPK激活的影响。此外,我们使用了水溶性的SB203580盐酸盐(SB203580.HCl)和DMSO来探究p38-MAPK在预处理和缺血性损伤中的作用。2. 在大鼠离体心脏插管、有氧灌注以及指数性、自溶性和预处理缺血过程中,使用双磷酸特异性抗体评估p38-MAPK的激活情况。以功能恢复和四氮唑(TTC)染色作为终点,测试了SB203580.HCl(10 mmol/L)在缺血预处理和缺血/再灌注中的作用。3. 有氧灌注在2分钟后诱导p38-MAPK快速激活(达到最大缺血诱导增加量的34%;P < 0.05),30分钟后恢复到基线水平。指数性、自溶性和预处理缺血激活了p38-MAPK,指数性缺血在15分钟后达到峰值(是基础值的520%;P < 0.05),随后下降。SB203580.HCl阻断了p38-MAPK活性,但在包围触发期时并未阻断缺血预处理,在缺血期间给予时也没有保护作用。4. 在大鼠离体心脏中,p38-MAPK的激活既不是预处理的独特特征,也不是其先决条件。以往使用SB203580的研究可能因未考虑该方案本身对p38-MAPK的激活以及最常用溶剂DMSO的抗氧化特性而变得复杂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验